BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33587147)

  • 1. Structure and elemental composition of Ceftriaxone induced pediatric nephrolithiasis.
    Du Y; Kang M; Mena J; Stoller ML; Ho SP; Li J
    Urolithiasis; 2021 Aug; 49(4):309-320. PubMed ID: 33587147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
    Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
    Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
    Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
    Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
    Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
    Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone crystallization and its potential role in kidney stone formation.
    Chutipongtanate S; Thongboonkerd V
    Biochem Biophys Res Commun; 2011 Mar; 406(3):396-402. PubMed ID: 21329669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
    Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
    Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute urine retention induced by ceftriaxone.
    Akl KF; Masri AT; Hjazeen MM
    Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1226-8. PubMed ID: 22089789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive Pseudolithiasis Associated with the Intravenous Administration of Ceftriaxone in Patients with Central Nervous System Infections.
    Tsukagoshi S; Ishizawa K; Hirayanagi K; Nagamine S; Makioka K; Fujita Y; Ikeda Y
    Intern Med; 2017 Dec; 56(23):3189-3192. PubMed ID: 29021458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible function of urinary pH and citrate on the ceftriaxone-induced nephrolithiasis.
    Cong X; Gu X; Sun X; Ning B; Shen L
    Urology; 2014 Jan; 83(1):63-7. PubMed ID: 24231212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary calcium excretion caused by ceftriaxone: possible association with urolithiasis.
    Kimata T; Kaneko K; Takahashi M; Hirabayashi M; Shimo T; Kino M
    Pediatr Nephrol; 2012 Apr; 27(4):605-9. PubMed ID: 22038204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Progress of Mechanisms of Ceftriaxone Associated Nephrolithiasis.
    Wang S; Huang X; Xu Q; Xu T
    Mini Rev Med Chem; 2017; 17(17):1584-1587. PubMed ID: 27488586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
    Prince JS; Senac MO
    Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Pediatric ceftriaxone nephrolithiasis.
    Avci Z; Karadag A; Odemis E; Catal F
    J Urol; 2005 Sep; 174(3):1153. PubMed ID: 16094092
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric ceftriaxone nephrolithiasis.
    Gargollo PC; Barnewolt CE; Diamond DA
    J Urol; 2005 Feb; 173(2):577-8. PubMed ID: 15643261
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic Use and Risk of Incident Kidney Stones in Female Nurses.
    Ferraro PM; Curhan GC; Gambaro G; Taylor EN
    Am J Kidney Dis; 2019 Dec; 74(6):736-741. PubMed ID: 31543288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
    Tasic V; Sofijanova A; Avramoski V
    Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
    [No Abstract]   [Full Text] [Related]  

  • 17. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
    Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
    Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children.
    Charnas R; Lüthi AR; Ruch W
    Pediatr Infect Dis J; 1997 Apr; 16(4):346-53. PubMed ID: 9109134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone-associated biliary pseudolithiasis in children.
    Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
    J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing urinary calcium excretion after ceftriaxone and cephalothin therapy in adults: possible association with urolithiasis.
    Otunctemur A; Ozbek E; Polat EC; Cekmen M; Dursun M; Cakir SS
    Urolithiasis; 2014 Apr; 42(2):105-8. PubMed ID: 24310104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.